Should dendritic cell-based tumor vaccination be incorporated into standard therapy for newly diagnosed glioblastoma patients?
about
Clinical efficacy of tumor antigen-pulsed DC treatment for high-grade glioma patients: evidence from a meta-analysisFormulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?Dendritic cell-based vaccine for the treatment of malignant glioma: a systematic review.Brain Tumor Immunotherapy: What have We Learned so Far?
P2860
Should dendritic cell-based tumor vaccination be incorporated into standard therapy for newly diagnosed glioblastoma patients?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Should dendritic cell-based tu ...... agnosed glioblastoma patients?
@en
Should dendritic cell-based tu ...... agnosed glioblastoma patients?
@nl
type
label
Should dendritic cell-based tu ...... agnosed glioblastoma patients?
@en
Should dendritic cell-based tu ...... agnosed glioblastoma patients?
@nl
prefLabel
Should dendritic cell-based tu ...... agnosed glioblastoma patients?
@en
Should dendritic cell-based tu ...... agnosed glioblastoma patients?
@nl
P2860
P356
P1476
Should dendritic cell-based tu ...... agnosed glioblastoma patients?
@en
P2093
Stefaan Van Gool
P2860
P304
P356
10.1586/ERN.12.107
P577
2012-10-01T00:00:00Z